🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

UBS cuts Remy Cointreau shares target on weak US sales and APAC challenges

EditorEmilio Ghigini
Published 10/08/2024, 03:58 PM
REMYY
-

On Tuesday, UBS has adjusted its outlook on Remy Cointreau SA (RCO:FP) (OTC: REMYY) shares, reducing the price target to €71.00 from the previous figure of €93.00, while retaining a Neutral stance on the stock.

The revision comes amid concerns over the company's second-quarter organic sales, which UBS estimates will decline by 17.5%, a steeper drop than the consensus estimate of a 13.3% decrease.

The analysis provided by UBS points to several factors contributing to the bearish forecast. In the United States, Remy Cointreau is experiencing ongoing inventory adjustments without a significant rebound in underlying sell-out trends.

The Asia-Pacific (APAC) region is facing challenges compared to the previous year, along with subdued trends in the European, Middle East, and African (EMEA) regions, where competition has intensified.

Remy Cointreau's stock performance has lagged in recent months, with investor sentiment shifting negatively. This shift is attributed to several concerns: weak sell-out trends for the company's US Cognac and Liqueurs & Spirits despite more favorable comparisons; difficult comparisons in China amidst a broader economic slowdown that may persist over the next few quarters; and the uncertain impact of potential government stimulus measures in China, which are expected to take time to implement.

Further risks include China's ongoing anti-dumping investigation into Cognac and the possibility of additional global geopolitical trade disputes.

Additionally, there is potential concern over the impact of a higher corporate tax rate in France following recent proposed legislative changes. These factors collectively contribute to the more cautious perspective on Remy Cointreau's near-term financial performance.

InvestingPro Insights

Recent data from InvestingPro sheds additional light on Remy Cointreau's financial situation, aligning with UBS's cautious outlook. The company's revenue growth has indeed been negative, with a 22.89% decline in the last twelve months as of Q4 2024, and an 18.2% quarterly decline in Q4 2024. This data supports UBS's concerns about declining sales and challenging market conditions.

Despite these headwinds, Remy Cointreau maintains some financial strengths. An InvestingPro Tip highlights the company's impressive gross profit margins, which stand at 71.19% for the last twelve months. This suggests that despite sales challenges, Remy Cointreau is still able to maintain pricing power for its premium spirits.

Another InvestingPro Tip notes that the company has maintained dividend payments for 25 consecutive years, indicating a commitment to shareholder returns even in challenging times. However, investors should note that the stock has taken a significant hit over the last six months, with a total return of -27.63%, reflecting the market's concerns about the company's near-term prospects.

For readers interested in a more comprehensive analysis, InvestingPro offers 6 additional tips for Remy Cointreau, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.